A reappraisal on botulinum toxin-a in trigeminal neuralgia

J Neurosurg Sci. 2021 Oct;65(5):543-544. doi: 10.23736/S0390-5616.20.05125-5. Epub 2020 Sep 28.

Authors

Alfio Spina¹, Luigia Brugliera², Filippo Gagliardi³, Nicola Boari³, Michele Bailo³, Francesco Calvanese³, Sandro Iannaccone², Pietro Mortini³

Affiliations

¹ Department of Neurosurgery and Gamma Knife Radiosurgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy - spina.alfio@hsr.it.
² Department of Rehabilitation and Functional Recovery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
³ Department of Neurosurgery and Gamma Knife Radiosurgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.

PMID: 32989977
DOI: 10.23736/S0390-5616.20.05125-5

No abstract available

MeSH terms

Botulinum Toxins, Type A*
Humans
Pain Measurement
Trigeminal Neuralgia* / drug therapy

Substances

Botulinum Toxins, Type A